9th Circ. Affirms Amgen Win In Late Off-Label Sales Row
The Ninth Circuit on Thursday sealed a win for Amgen Inc. in a proposed class action alleging the company pushed off-label uses of anemia drug Aranesp, finding the suit was time-barred...To view the full article, register now.
Already a subscriber? Click here to view full article